LFG
CHRS icon

Larson Financial Group’s Coherus Oncology CHRS Stock Holding History

Larson Financial Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68 Buy
+40
New +$71 ﹤0.01% 3536
2025
Q3 		– Sell
-79
Closed -$58 – 3477
2025
Q2 		$58 Buy
+79
New +$68 ﹤0.01% 3222
2025
Q1 		– Sell
-147
Closed -$203 – 3089
2024
Q4 		$203 Hold
147
– – ﹤0.01% 2438
2024
Q3 		$153 Sell
147
-71,343
-100% -$97.8K ﹤0.01% 2445
2024
Q2 		$124K Sell
71,490
-2,471
-3% -$4.97K 0.01% 593
2024
Q1 		$177K Buy
73,961
+73,814
+50,214% +$182K 0.01% 438
2023
Q4 		$490 Hold
147
– – ﹤0.01% 1579
2023
Q3 		$550 Buy
+147
New +$679 ﹤0.01% 1569
2023
Q2 		– Sell
-27,409
Closed -$187K – 1577
2023
Q1 		$187K Buy
+27,409
New +$213K 0.02% 318

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return